CN105748826A - Traditional Chinese medicine composition for regulating spleen-stomach disharmony as well as oral liquid and preparation method thereof - Google Patents
Traditional Chinese medicine composition for regulating spleen-stomach disharmony as well as oral liquid and preparation method thereof Download PDFInfo
- Publication number
- CN105748826A CN105748826A CN201610218820.7A CN201610218820A CN105748826A CN 105748826 A CN105748826 A CN 105748826A CN 201610218820 A CN201610218820 A CN 201610218820A CN 105748826 A CN105748826 A CN 105748826A
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- medicine composition
- oral liquid
- traditional chinese
- taste
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 107
- 239000003814 drug Substances 0.000 title claims abstract description 94
- 239000007788 liquid Substances 0.000 title claims abstract description 51
- 238000002360 preparation method Methods 0.000 title claims abstract description 15
- 230000001105 regulatory effect Effects 0.000 title abstract description 6
- 244000268590 Euryale ferox Species 0.000 claims abstract description 10
- 235000006487 Euryale ferox Nutrition 0.000 claims abstract description 10
- 241000628997 Flos Species 0.000 claims abstract description 7
- 210000000582 semen Anatomy 0.000 claims description 28
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 24
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 20
- 238000000034 method Methods 0.000 claims description 17
- 230000008569 process Effects 0.000 claims description 14
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 12
- 239000002671 adjuvant Substances 0.000 claims description 12
- 239000012531 culture fluid Substances 0.000 claims description 12
- 239000001963 growth medium Substances 0.000 claims description 12
- 239000003208 petroleum Substances 0.000 claims description 12
- 239000002994 raw material Substances 0.000 claims description 12
- 210000004185 liver Anatomy 0.000 claims description 10
- 240000008669 Hedera helix Species 0.000 claims description 8
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 6
- 108010010803 Gelatin Proteins 0.000 claims description 6
- 239000001888 Peptone Substances 0.000 claims description 6
- 108010080698 Peptones Proteins 0.000 claims description 6
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 6
- 244000269722 Thea sinensis Species 0.000 claims description 6
- 235000006468 Thea sinensis Nutrition 0.000 claims description 6
- 235000020279 black tea Nutrition 0.000 claims description 6
- 238000000605 extraction Methods 0.000 claims description 6
- 229920000159 gelatin Polymers 0.000 claims description 6
- 239000008273 gelatin Substances 0.000 claims description 6
- 235000019322 gelatine Nutrition 0.000 claims description 6
- 235000011852 gelatine desserts Nutrition 0.000 claims description 6
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 claims description 6
- 235000003969 glutathione Nutrition 0.000 claims description 6
- 229960003180 glutathione Drugs 0.000 claims description 6
- 238000011534 incubation Methods 0.000 claims description 6
- 235000019319 peptone Nutrition 0.000 claims description 6
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical group [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 claims description 6
- 239000011780 sodium chloride Substances 0.000 claims description 6
- 238000001694 spray drying Methods 0.000 claims description 6
- 241001264174 Cordyceps militaris Species 0.000 claims description 5
- 239000000706 filtrate Substances 0.000 claims description 5
- 238000001914 filtration Methods 0.000 claims description 5
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 4
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims description 4
- 239000005018 casein Substances 0.000 claims description 4
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 claims description 4
- 235000021240 caseins Nutrition 0.000 claims description 4
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims description 4
- 239000008108 microcrystalline cellulose Substances 0.000 claims description 4
- 229940016286 microcrystalline cellulose Drugs 0.000 claims description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 3
- 229930003427 Vitamin E Natural products 0.000 claims description 3
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 3
- 239000008280 blood Substances 0.000 claims description 3
- 210000004369 blood Anatomy 0.000 claims description 3
- 239000008119 colloidal silica Substances 0.000 claims description 3
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 3
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 3
- 235000019165 vitamin E Nutrition 0.000 claims description 3
- 229940046009 vitamin E Drugs 0.000 claims description 3
- 239000011709 vitamin E Substances 0.000 claims description 3
- 239000000811 xylitol Substances 0.000 claims description 3
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 3
- 229960002675 xylitol Drugs 0.000 claims description 3
- 235000010447 xylitol Nutrition 0.000 claims description 3
- 229920001218 Pullulan Polymers 0.000 claims description 2
- 239000004373 Pullulan Substances 0.000 claims description 2
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 claims description 2
- -1 isopropyl cetylate Chemical compound 0.000 claims description 2
- 235000019423 pullulan Nutrition 0.000 claims description 2
- 229940080313 sodium starch Drugs 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 27
- 244000037364 Cinnamomum aromaticum Species 0.000 abstract 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 abstract 1
- 235000002722 Dioscorea batatas Nutrition 0.000 abstract 1
- 235000006536 Dioscorea esculenta Nutrition 0.000 abstract 1
- 240000001811 Dioscorea oppositifolia Species 0.000 abstract 1
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 abstract 1
- 241000208682 Liquidambar Species 0.000 abstract 1
- 235000006552 Liquidambar styraciflua Nutrition 0.000 abstract 1
- 235000006751 Platycodon Nutrition 0.000 abstract 1
- 244000274050 Platycodon grandiflorum Species 0.000 abstract 1
- 235000010580 Psophocarpus tetragonolobus Nutrition 0.000 abstract 1
- 241001278833 Rosa laevigata Species 0.000 abstract 1
- 235000000661 Rosa laevigata Nutrition 0.000 abstract 1
- 241001409305 Siraitia Species 0.000 abstract 1
- 241000046198 Triteleia hyacinthina Species 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 229930189914 platycodon Natural products 0.000 abstract 1
- 239000011347 resin Substances 0.000 abstract 1
- 229920005989 resin Polymers 0.000 abstract 1
- 238000012360 testing method Methods 0.000 description 39
- 208000024891 symptom Diseases 0.000 description 14
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 12
- 238000007796 conventional method Methods 0.000 description 11
- 230000000052 comparative effect Effects 0.000 description 8
- 230000001225 therapeutic effect Effects 0.000 description 8
- 230000003516 hyperlipidaemic effect Effects 0.000 description 7
- 208000031226 Hyperlipidaemia Diseases 0.000 description 6
- 235000012000 cholesterol Nutrition 0.000 description 6
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 6
- 208000019790 abdominal distention Diseases 0.000 description 5
- 238000004090 dissolution Methods 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 210000000952 spleen Anatomy 0.000 description 5
- 230000008859 change Effects 0.000 description 4
- 230000010354 integration Effects 0.000 description 4
- 230000002159 abnormal effect Effects 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- AIUDWMLXCFRVDR-UHFFFAOYSA-N dimethyl 2-(3-ethyl-3-methylpentyl)propanedioate Chemical class CCC(C)(CC)CCC(C(=O)OC)C(=O)OC AIUDWMLXCFRVDR-UHFFFAOYSA-N 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 229940066779 peptones Drugs 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 150000003722 vitamin derivatives Chemical class 0.000 description 3
- 206010003591 Ataxia Diseases 0.000 description 2
- 206010010947 Coordination abnormal Diseases 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 208000016290 incoordination Diseases 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 239000002932 luster Substances 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 238000007619 statistical method Methods 0.000 description 2
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010013082 Discomfort Diseases 0.000 description 1
- 208000036649 Dysbacteriosis Diseases 0.000 description 1
- 208000027244 Dysbiosis Diseases 0.000 description 1
- 206010053155 Epigastric discomfort Diseases 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 240000005373 Panax quinquefolius Species 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 238000003759 clinical diagnosis Methods 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000007140 dysbiosis Effects 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000000556 factor analysis Methods 0.000 description 1
- 230000030135 gastric motility Effects 0.000 description 1
- 230000002650 habitual effect Effects 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 230000037111 immune power Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 230000035943 smell Effects 0.000 description 1
- 238000013112 stability test Methods 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 239000008802 xuezhikang Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
- A61K36/8994—Coix (Job's tears)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/062—Ascomycota
- A61K36/066—Clavicipitaceae
- A61K36/068—Cordyceps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/282—Artemisia, e.g. wormwood or sagebrush
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
- A61K36/346—Platycodon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/482—Cassia, e.g. golden shower tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/56—Loganiaceae (Logania family), e.g. trumpetflower or pinkroot
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/62—Nymphaeaceae (Water-lily family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
- A61K36/725—Ziziphus, e.g. jujube
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/738—Rosa (rose)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/82—Theaceae (Tea family), e.g. camellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/894—Dioscoreaceae (Yam family)
- A61K36/8945—Dioscorea, e.g. yam, Chinese yam or water yam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8969—Polygonatum (Solomon's seal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/19—Preparation or pretreatment of starting material involving fermentation using yeast, bacteria or both; enzymatic treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Alternative & Traditional Medicine (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Inorganic Chemistry (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention provides a traditional Chinese medicine composition for regulating spleen-stomach disharmony. The traditional Chinese medicine composition is mainly prepared from Chinese yam, cassia seed, platycodon root, grosvener siraitia, white hyacinth bean, gordon euryale seed, flos buddlejae, herba cichorii, cherokee rose fruit and resin of sweetgum. Moreover, the invention also provides oral liquid of the traditional Chinese medicine composition and a preparation method of the traditional Chinese medicine composition. The traditional Chinese medicine composition has a significant curative effect on patients with spleen-stomach disharmony; the preparation has very good stability and very high bioavailability; and the preparation method of the traditional Chinese medicine composition can effectively extract active ingredients of various raw medicinal materials, thereby more significantly improving the curative effect of regulating the spleen-stomach disharmony.
Description
Technical field
The invention belongs to the field of Chinese medicines, regulate, particularly to a kind of, the Chinese medicine composition and oral liquid thereof and preparation method that taste become estranged.
Background technology
Along with the development of society, the deterioration of environment and the increasing of life stress, the phychology of people is unbalance, causes the physiological function senilism of human body.Taste are become estranged, high liver fire is contained is its key factor；Show as the symptoms such as habitual constipation is suffered from diarrhoea, complexion is turned white, coldness of the body with chills.
The compositions that disclosed in prior art, many adjustment taste are become estranged, for instance: CN103041282 discloses a kind of Chinese medicine treating asthenia of both the spleen and kidney and preparation method thereof, it is made up of Poria, Radix Rehmanniae Preparata, Radix Glycyrrhizae Preparata, Semen Euryales etc.；CN105055995 discloses a kind of Chinese medicine treating incoordination between the spleen and stomach, its by Flos Buddlejae, the moon Herba mesonae chinensis etc. form, etc.；The regulating effect that taste are become estranged by compositions majority disclosed in prior art is poor, and the content of the effective ingredient extracted is low, and the content of active substance is relatively high, causes that the cure rate of the Chinese medicine composition of prior art is low, affects its curative effect.
Summary of the invention
In order to solve above-mentioned technical problem, the present invention provides a kind of and regulates the Chinese medicine composition that taste are become estranged, and said composition has effect that significantly high adjustment taste are become estranged.
The concrete technical scheme of the present invention is as follows:
The present invention provides a kind of and regulates the Chinese medicine composition that taste are become estranged, and this Chinese medicine composition is mainly prepared from by the raw material of following weight portion:
The present invention is drawn by substantial amounts of test, adopts the Chinese medicine composition that the 10 taste crude drug such as Rhizoma Dioscoreae, Semen Cassiae, Radix Platycodonis are prepared from that adjustment taste are become estranged and has good effect, and effective percentage can reach more than 88%.
Preferably, the raw materials used raw material also including following weight portion of described Chinese medicine composition is prepared:
Black tea 10-15 Poria 5-10 Rhizoma Polygonati 40-50
Semen Coicis 5-15 Pericarpium Citri Reticulatae 15-20 Fructus Jujubae 5-10
Cordyceps militaris (L.) Link. 25-35 Radix Glycyrrhizae Preparata 12-20.
Not only significantly improve said composition by the Chinese medicine composition prepared after adding the 7 taste crude drug such as black tea and regulate effect that taste are become estranged, can effectively improve the body cards such as patient's high liver fire simultaneously.
Further improve, prepare the raw materials used raw material also including following weight portion of described Chinese medicine composition:
Herba Lycopodii 15-20 Herba Artemisiae Annuae 5-10 FRUCTUS TERMINALIAE IMMATURUS 20-30.
Not only significantly improve said composition by the Chinese medicine composition prepared after adding above-mentioned 3 taste crude drug and regulate effect that taste are become estranged, additionally play effect of blood fat reducing.
A kind of regulating the Chinese medicine composition that taste are become estranged, this Chinese medicine composition is mainly prepared from by the raw material of following weight portion:
Rhizoma Dioscoreae 20-30 Semen Cassiae 20-30 Radix Platycodonis 20-30
Fructus Momordicae 10-20 Semen Lablab Album 5-10 Semen Euryales 5-10
Black tea 10-15 Poria 5-10 Rhizoma Polygonati 40-50 Fructus Jujubae 5-10
Semen Coicis 5-15 Pericarpium Citri Reticulatae 15-20 Cordyceps militaris (L.) Link. 25-35
Radix Glycyrrhizae Preparata 12-20.
In order to carry and easy to use, Chinese medicine composition and adjuvant and water are made oral liquid by the present invention, and wherein, in described oral liquid, the ratio of weight and number of Chinese medicine composition, adjuvant and water is 1:0.5-1.5:3-5.
Further improving, it is 1-3 part Pullulan, 0.5-1 part isopropyl cetylate and 1.5-2.4 part sodium starch glycol that described adjuvant includes parts by weight.The present invention can significantly improve the dissolubility of Chinese medicine composition in oral liquid by adding above-mentioned 3 kinds of adjuvants, it is possible to promotes the absorption of this Chinese medicine composition.
Further improving, it is 0.3-0.5 part casein and 1-2 part microcrystalline Cellulose that described adjuvant also includes parts by weight.By adding the mixture of casein and microcrystalline Cellulose in adjuvant, it plays the effect improving stability of Oral.One-year age can be preserved under hot and humid environment, occur without muddy and deposited phenomenon.
Further improving, it is 0.4-0.7 part colloidal silica and 0.1-0.3 part xylitol that described adjuvant also includes parts by weight.Effect of anti-corrosive antibacterial can be played by adding the mixture of colloidal silica and xylitol.
The preparation method that another aspect of the present invention additionally provides Chinese medicine composition, the method comprises the steps:
1) Rhizoma Dioscoreae, Semen Cassiae, Radix Platycodonis, Fructus Momordicae, Semen Lablab Album and Semen Euryales are pulverized, it is inoculated in the culture tank containing profitable probliotics, add culture medium to cultivate, condition of culture is: initial ph value is 5.2-5.4, cultivation temperature 28-30 DEG C, shaking speed 200-220 rev/min, incubation time 3-5 days, it is thus achieved that culture fluid；Described culture medium is that 1-2 part peptone, 2-3 part gelatin, 5-10 part glutathion, 3-6 part tristerin, 1-2 part vitamin E, 2-5 part sodium chloride and 0.5-1 part potassium dihydrogen phosphate form by parts by weight；
2) by step 1) culture fluid that obtains is sonicated, and the time of supersound process is 5-10min, and ultrasonic power is 80-100kHz；
3) by the ferment in second time liquid petroleum ether extraction three times through supersound process, discard petroleum ether layer, collect water layer；
4) Flos Buddlejae, Herba Cichorii, Fructus Rosae Laevigatae and Resina Liquidambaris are joined in 5-7 times amount water, decoct 1-2h, decocts 3 times, merge decoction liquor, filtration, then by filtrate and step 3) water layer collected merges, and spray drying prepares Chinese medicine composition.
The content that the Chinese medicine composition prepared by above method is remarkably improved in compositions active component, makes the Chinese medicine composition of preparation have and regulates effect that taste are become estranged higher.
The present invention provides a kind of and regulates the Chinese medicine composition that taste are become estranged, and said composition has effect that well adjustment taste are become estranged, and simultaneously to adjusting the body cards such as high liver fire Sheng, reduces blood fat and is respectively provided with the curative effect arrived very much.
Detailed description of the invention
Embodiment 1
A kind of Chinese medicine composition, this Chinese medicine composition is grouped into by the one-tenth of following weight:
Embodiment 2
A kind of Chinese medicine composition, this Chinese medicine composition is grouped into by the one-tenth of following weight:
The preparation method of this Chinese medicine composition is as follows:
1) Rhizoma Dioscoreae, Semen Cassiae, Radix Platycodonis, Fructus Momordicae, Semen Lablab Album and Semen Euryales are pulverized, be inoculated in the culture tank containing profitable probliotics, add culture medium and cultivate, condition of culture is: initial ph value is 5.2, cultivation temperature 28 DEG C, shaking speed 200 revs/min, incubation time 3 days, it is thus achieved that culture fluid；Described culture medium is that 1 part of peptone, 2 parts of gelatin, 5 parts of glutathion, 3 parts of tristerins, 1 part of vitamin E, 2 parts of sodium chloride and 0.5 part of potassium dihydrogen phosphate form by parts by weight；
2) by step 1) culture fluid that obtains is sonicated, and the time of supersound process is 5min, and ultrasonic power is 80kHz；
3) by the ferment in second time liquid petroleum ether extraction three times through supersound process, discard petroleum ether layer, collect water layer；
4) Flos Buddlejae, Herba Cichorii, Fructus Rosae Laevigatae and Resina Liquidambaris are joined in 5 times amount water, decoct 2h, decocts 3 times, merge decoction liquor, filtration, then by filtrate and step 3) water layer collected merges, and spray drying prepares Chinese medicine composition.
Embodiment 3
A kind of Chinese medicine composition, this Chinese medicine composition is grouped into by the one-tenth of following weight:
Embodiment 4
A kind of Chinese medicine composition, this Chinese medicine composition is grouped into by the one-tenth of following weight:
The preparation method of this Chinese medicine composition is as follows:
1) Rhizoma Dioscoreae, Semen Cassiae, Radix Platycodonis, Fructus Momordicae, Semen Lablab Album, Semen Euryales, black tea, Poria, Rhizoma Polygonati, Semen Coicis, Pericarpium Citri Reticulatae, Fructus Jujubae, Cordyceps militaris (L.) Link. and Radix Glycyrrhizae Preparata are pulverized, it is inoculated in the culture tank containing profitable probliotics, add culture medium to cultivate, condition of culture is: initial ph value is 5.4, cultivation temperature 30 DEG C, shaking speed 220 revs/min, incubation time 5 days, it is thus achieved that culture fluid；Described culture medium is that 2 parts of peptones, 3 parts of gelatin, 10 parts of glutathion, 6 parts of tristerins, 2 parts of vitamin Es, 5 parts of sodium chloride and 1 part of potassium dihydrogen phosphate form by parts by weight；
2) by step 1) culture fluid that obtains is sonicated, and the time of supersound process is 10min, and ultrasonic power is 100kHz；
3) by the ferment in second time liquid petroleum ether extraction three times through supersound process, discard petroleum ether layer, collect water layer；
4) Flos Buddlejae, Herba Cichorii, Fructus Rosae Laevigatae and Resina Liquidambaris are joined in 7 times amount water, decoct 1h, decocts 3 times, merge decoction liquor, filtration, then by filtrate and step 3) water layer collected merges, and spray drying prepares Chinese medicine composition.
Embodiment 5
A kind of Chinese medicine composition, this Chinese medicine composition is grouped into by the one-tenth of following weight:
Embodiment 6
A kind of Chinese medicine composition, this Chinese medicine composition is grouped into by the one-tenth of following weight:
The preparation method of this Chinese medicine composition is as follows:
1) Rhizoma Dioscoreae, Semen Cassiae, Radix Platycodonis, Fructus Momordicae, Semen Lablab Album and Semen Euryales are pulverized, be inoculated in the culture tank containing profitable probliotics, add culture medium and cultivate, condition of culture is: initial ph value is 5.3, cultivation temperature 29 DEG C, shaking speed 210 revs/min, incubation time 4 days, it is thus achieved that culture fluid；Described culture medium is that 1.5 parts of peptones, 2.5 parts of gelatin, 7 parts of glutathion, 5 parts of tristerins, 1.5 parts of vitamin Es, 3 parts of sodium chloride and 0.7 part of potassium dihydrogen phosphate form by parts by weight；
2) by step 1) culture fluid that obtains is sonicated, and the time of supersound process is 7min, and ultrasonic power is 90kHz；
3) by the ferment in second time liquid petroleum ether extraction three times through supersound process, discard petroleum ether layer, collect water layer；
4) Flos Buddlejae, Herba Cichorii, Fructus Rosae Laevigatae, Resina Liquidambaris, Herba Lycopodii, Herba Artemisiae Annuae and FRUCTUS TERMINALIAE IMMATURUS are joined in 6 times amount water, decoct 2h, decoct 3 times, merge decoction liquor, filtering, then by filtrate and step 3) water layer collected merges, and spray drying prepares Chinese medicine composition.
Embodiment 7
A kind of Chinese medicine composition, this Chinese medicine composition is grouped into by the one-tenth of following weight:
Embodiment 8
A kind of Chinese medicine composition, this Chinese medicine composition is grouped into by the one-tenth of following weight:
The preparation method of this Chinese medicine composition is as follows:
1) Rhizoma Dioscoreae, Semen Cassiae, Radix Platycodonis, Fructus Momordicae, Semen Lablab Album, Semen Euryales, black tea, Poria, Rhizoma Polygonati, Semen Coicis, Pericarpium Citri Reticulatae, Fructus Jujubae, Cordyceps militaris (L.) Link. and Radix Glycyrrhizae Preparata are pulverized, it is inoculated in the culture tank containing profitable probliotics, add culture medium to cultivate, condition of culture is: initial ph value is 5.4, cultivation temperature 30 DEG C, shaking speed 220 revs/min, incubation time 5 days, it is thus achieved that culture fluid；Described culture medium is that 2 parts of peptones, 3 parts of gelatin, 10 parts of glutathion, 6 parts of tristerins, 2 parts of vitamin Es, 5 parts of sodium chloride and 1 part of potassium dihydrogen phosphate form by parts by weight；
2) by step 1) culture fluid that obtains is sonicated, and the time of supersound process is 10min, and ultrasonic power is 100kHz；
3) by the ferment in second time liquid petroleum ether extraction three times through supersound process, discarding petroleum ether layer, collect water layer, filter, spray drying prepares Chinese medicine composition.
Embodiment 9 oral liquid
The consumption of each composition of oral liquid is:
Prepared by conventional method.
Embodiment 10 oral liquid
The consumption of each composition of oral liquid is:
Prepared by conventional method.
Embodiment 11 oral liquid
The consumption of each composition of oral liquid is:
Prepared by conventional method.
Embodiment 12 oral liquid
The consumption of each composition of oral liquid is:
Prepared by conventional method.
Embodiment 13 oral liquid
The consumption of each composition of oral liquid is:
Prepared by conventional method.
Embodiment 14
The consumption of each composition of oral liquid is:
Prepared by conventional method.
Embodiment 15 oral liquid
The consumption of each composition of oral liquid is:
Prepared by conventional method.
Reference examples 1 oral liquid
The consumption of each composition of oral liquid is:
Prepared by conventional method.
Reference examples 2 oral liquid
The consumption of each composition of oral liquid is:
Prepared by conventional method.
Reference examples 3 oral liquid
The consumption of each composition of oral liquid is:
Prepared by conventional method.
Reference examples 4 oral liquid
The consumption of each composition of oral liquid is:
Prepared by conventional method.
Reference examples 5
A kind of Chinese medicine composition, this Chinese medicine composition is grouped into by the one-tenth of following weight:
Rhizoma Dioscoreae 20g Semen Cassiae 20g Radix Platycodonis 20g
Fructus Momordicae 10g Semen Lablab Album 5g Semen Euryales 5g.
Reference examples 6
A kind of Chinese medicine composition, this Chinese medicine composition is grouped into by the one-tenth of following weight:
Test example 1 vitro release determination test
The drug release rate detection of oral liquid: check with reference to 2010 editions version " Chinese Pharmacopoeia " annex XIXD vitro drug release degree.
Take the oral liquid of above example 9, reference examples 1 and reference examples 2 respectively, put in medicament dissolution instrument, separately sampled in 1h, 2h, 4h, 6h, 12h, 16h, 24h, detect dissolution percentage rate by high performance liquid chromatography, and calculating the cumulative release percentage rate of medicine, result is in Table 1.
Dissolution (%) result of the test of table 1 inventive samples
The whole dissolution of the oral liquid of embodiment 9 effective ingredient in 12h as can be seen from the table, and the oral liquid of comparative examples 1-2 still has fractions not have dissolution in 24h, and then affect its curative effect.
Test example 2 stability test
1. accelerated test
The oral liquid of Example 12, comparative examples 3 and comparative examples 4, all at temperature 40 DEG C ± 2 DEG C, place 6 months when relative humidity is 75% ± 5%, testing, 1 month period, 2 months, 3 months, 6 the end of month are separately sampled once, the detection character of oral liquid, color and luster, abnormal smells from the patient, main constituent content (labelled amount %), moisture, it was found that the indices of embodiment 12 has no significant change；And the color of the oral liquid of comparative examples 3 and comparative examples 4 substantially deepens, and precipitation occurs.
2. long term test
The oral liquid of Example 12, comparative examples 3 and comparison 4, all at temperature 25 DEG C ± 2 DEG C, place 12 months when relative humidity is 60% ± 10%, testing, 0 month period, 3 months, 6 months, 9 months, 12 the end of month are separately sampled once, the detection character of oral liquid, color and luster, main constituent content (labelled amount %), moisture, it was found that the indices of embodiment 10 has no significant change；And the color of the oral liquid of comparative examples 3 and comparative examples 4 substantially deepens, the content of main component is decreased obviously, and muddy and precipitation occurs.
It can be seen that the mixture of casein and microcrystalline Cellulose is remarkably improved the stability of oral liquid from accelerated test and long term test, lacking one of them composition, or change one of them composition, the stability of oral liquid declines.
Test example 3 effectiveness comparison
One, the effect that taste are become estranged
(1) tcm diagnosis standard
Main symptom: distension and fullness in the abdomen, unsuitable diet, feel sick, dark tongue quality, yellow fur；
(2) Chinese medical discrimination
Pattern of syndrome: dysfunction of the spleen in transportation, incoordination between the spleen and stomach；
(3) Western medicine diagnose standard
The intestines and stomach dysbacteriosis, gastric motility declines, and central functions is lacked of proper care, cause feel sick, minimizings of abdominal distention, diet, epigastric discomfort etc. are demonstrate,proved；
(4) test crowd
175 examples meet taste and become estranged the experimenter of symptom, and the age is all between 25-60 year.
(5) packet
The experimenter that become estranged by 175 example taste is randomly divided into 1 group of 25 people of test, tests 2 group of 25 people, tests 3 group of 25 people, test 4 group of 25 people, tests 5 group of 25 people, compares 1 group of 25 people and 2 group of 25 people of comparison；Test 1 group and use the embodiment of the present invention, the Chinese medicine composition described in 7；Test 2 groups of Chinese medicine compositions using the embodiment of the present invention 8；Test 3 groups of Chinese medicine compositions using the embodiment of the present invention 1；Test 4 groups of Chinese medicine compositions using the embodiment of the present invention 2；Test 5 groups of Chinese medicine compositions using the embodiment of the present invention 3；Compare 1 group of Chinese medicine composition using reference examples 5；Compare 2 groups of Chinese medicine compositions using reference examples 6；6 groups all use 6 months.
(6) functional evaluation
1. curative effect observation
According to the guideline of clinical investigations that Chinese traditional treatment taste are become estranged, specially formulate the card classification of symptom body and curative effect judging standard
A degree is standards of grading
Violent abdominal distention 3 points of moderate abdominal distention of 4 points of severe abdominal distention 2 points
Normal 0 point of slight abdominal distention 1 point
B is with fed state for standards of grading
Do not take food completely 4 points and only enter seldom food 3 points and eat less food person 2 points
Trencherman 0 point is normally entered than normal feed less slightly person 1 point
Relatively 4 points of temper discomforts of severe one are lighter 3 points for temper discomfort
Spleen district without uncomfortable, dizzy, feel sick 2 points nearly dizzy 1 point normal 0 point
2. Outcome measure
Recovery from illness: clinical symptoms, body card integration reduces >=95%；
Effective: clinical symptoms, body card integration reduces 70-90%；
Effective: clinical symptoms, body card integration reduces 50-70%；
Invalid: clinical symptoms, body card integration reduces≤50%；
(7) statistical analysis
Test data adopt spss10.0 software carry out statistical analysis, measurement data withComparing employing t inspection between group, in group, different time points compare employing one factor analysis of variance, and P < 0.05 is variant.
(8) result
The result of 7 groups of subject immune's power changes is in Table 2；
27 groups of compositionss of table regulate effectiveness comparison that taste become estranged ()
Test 1-5 group is compared with compareing 1 group and comparison 2 groups, and the adjustment curative effect that taste are become estranged there are differences (P < 0.05).
(9) conclusion
After using the Chinese medicine composition of embodiment 1-3 and embodiment 7-8, every body card that patient's taste are become estranged can be significantly improved；But test 2-5 group regulating effect is apparently higher than testing 1 group, there is significant difference with matched group.
Two, the therapeutic effect to high liver fire
1. physical data:
Body is demonstrate,proved: often feel fatigue, conjunctival congestion, liver-fire weight, irritability；Age is between 25-50 year；
2. packet and administration: 75 example high liver fire patients are randomly divided into 3 groups, often organize 25 people, test 1 group: use the Chinese medicine composition described in the embodiment of the present invention 1；Test 2 groups of Chinese medicine compositions using the embodiment of the present invention 3；Compare 1 group of Chinese medicine composition using CN105381200 disclosed treatment hyperactivity of hesrt-fire and liver-fire；It within 4 weeks, it is a course for the treatment of；
3. observation index: observe the body card before and after treatment；
4. curative effect determinate standard:
Cure: clinical symptoms body card disappears；
Effective: clinical symptoms body card is basic to disappear；
Effective: clinical symptoms body is demonstrate,proved big portion and disappeared；
Invalid: unchanged；
5. therapeutic outcome
Test group and matched group to the therapeutic effect of high liver fire respectively in Table 3.
Each group of therapeutic effect to high liver fire of table 3 compares
Test 2 groups with test 1 group, compare 1 group of curative effect to high liver fire and there are differences (P < 0.05).
6. conclusion: it is 100% to the effective percentage of high liver fire that the present invention tests 2 groups of compositionss provided, and curative effect is superior to matched group；In verifying its curative effect process, do not find any untoward reaction and abnormal phenomena.
Three, the therapeutic effect to hyperlipidemia
1. physical data: for investigating the clinical efficacy of the present composition further, selects 75 example hyperlipemic patients that the curative effect of oral liquid of the present invention is carried out clinical observation；This 75 example MethodsThe cases enrolled all meets the diagnostic criteria of hyperlipidemia；Cholesterol >=15.72mmol/L, triglyceride >=2.26mmol/L confirmation is hyperlipemic patients；Age is between 25-50 year；
2. packet and administration: 75 example hyperlipemic patients are randomly divided into 3 groups, often organize 25 people, test 1 group: use the Chinese medicine composition described in the embodiment of the present invention 1；Test 2 groups of Chinese medicine compositions using the embodiment of the present invention 5；Compare 1 group and use Xuezhikang；It within 4 weeks, it is a course for the treatment of；
3. observation index: observe the change of the amount of cholesterol and triglyceride before and after treatment；
4. curative effect determinate standard: according to country " clinical diagnosis is according to curing improvement standard "
Cure: clinical symptoms body card disappears, and the cholesterol of hyperlipemic patients and the recovery of triglyceride are normal；
Effective: clinical symptoms body card is basic to disappear, and the cholesterol of hyperlipemic patients declines more than 20%, or the amount of triglyceride declines 40%；
Effective: clinical symptoms body is demonstrate,proved big portion and disappeared, and the cholesterol of hyperlipemic patients declines at 10%-20%, or the amount of triglyceride drops to 20%-40%；
Invalid: the cholesterol of hyperlipemic patients and the amount of triglyceride are unchanged；
5. therapeutic outcome
Test group and matched group to the therapeutic effect of hyperlipidemia respectively in Table 4.
Each group of therapeutic effect to hyperlipidemia of table 4 compares
Test 2 groups with test 1 group, compare 1 group of curative effect to hyperlipidemia and there are differences (P < 0.05).
6. conclusion: it is 96.0% to the effective percentage of hyperlipidemia that the present invention tests 2 groups of compositionss provided, and curative effect is superior to matched group；In verifying its curative effect process, do not find any untoward reaction and abnormal phenomena.
Claims (10)
1. one kind regulates the Chinese medicine composition that taste are become estranged, it is characterised in that described Chinese medicine composition is mainly prepared from by the raw material of following weight portion:
2. the Chinese medicine composition that adjustment taste as claimed in claim 1 are become estranged, it is characterised in that prepare the raw materials used raw material also including following weight portion of described Chinese medicine composition:
Black tea 10-15 Poria 5-10 Rhizoma Polygonati 40-50
Semen Coicis 5-15 Pericarpium Citri Reticulatae 15-20 Fructus Jujubae 5-10
Cordyceps militaris (L.) Link. 25-35 Radix Glycyrrhizae Preparata 12-20.
3. the Chinese medicine composition that adjustment taste as claimed in claim 1 are become estranged, it is characterised in that prepare the raw materials used raw material also including following weight portion of described Chinese medicine composition:
Herba Lycopodii 15-25 Herba Artemisiae Annuae 5-10 FRUCTUS TERMINALIAE IMMATURUS 20-30.
4. one kind regulates the Chinese medicine composition that taste are become estranged, it is characterised in that described Chinese medicine composition is mainly prepared from by the raw material of following weight portion:
5. an oral liquid, the arbitrary described adjustment taste of claim 1-4 Chinese medicine composition, adjuvant and the water become estranged form, it is characterised in that the ratio of weight and number of described Chinese medicine composition, adjuvant and water is 1:0.5-1.5:3-5.
6. oral liquid as claimed in claim 5, it is characterised in that it is 1-3 part Pullulan, 0.5-1 part isopropyl cetylate and 1.5-2.4 part sodium starch glycol that described adjuvant includes parts by weight.
7. oral liquid as claimed in claim 6, it is characterised in that it is 0.3-0.5 part casein and 1-2 part microcrystalline Cellulose that described adjuvant also includes parts by weight.
8. oral liquid as claimed in claim 7, it is characterised in that it is 0.4-0.7 part colloidal silica and 0.1-0.3 part xylitol that described adjuvant also includes parts by weight.
9. the preparation method of the Chinese medicine composition described in a claim 1, it is characterised in that described method comprises the steps:
1) Rhizoma Dioscoreae, Semen Cassiae, Radix Platycodonis, Fructus Momordicae, Semen Lablab Album and Semen Euryales are pulverized, it is inoculated in the culture tank containing profitable probliotics, add culture medium to cultivate, condition of culture is: initial ph value is 5.2-5.4, cultivation temperature 28-30 DEG C, shaking speed 200-220 rev/min, incubation time 3-5 days, it is thus achieved that culture fluid；Described culture medium is that 1-2 part peptone, 2-3 part gelatin, 5-10 part glutathion, 3-6 part tristerin, 1-2 part vitamin E, 2-5 part sodium chloride and 0.5-1 part potassium dihydrogen phosphate form by parts by weight；
2) by step 1) culture fluid that obtains is sonicated, and the time of supersound process is 5-10min, and ultrasonic power is 80-100kHz；
3) by the ferment in second time liquid petroleum ether extraction three times through supersound process, discard petroleum ether layer, collect water layer；
4) Flos Buddlejae, Herba Cichorii, Fructus Rosae Laevigatae and Resina Liquidambaris are joined in 5-7 times amount water, decoct 1-2h, decocts 3 times, merge decoction liquor, filtration, then by filtrate and step 3) water layer collected merges, and spray drying prepares Chinese medicine composition.
10. the arbitrary described Chinese medicine composition of claim 1-4 preparation regulate taste become estranged, application in the medicine of high liver fire, reduction blood fat.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610218820.7A CN105748826A (en) | 2016-04-08 | 2016-04-08 | Traditional Chinese medicine composition for regulating spleen-stomach disharmony as well as oral liquid and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610218820.7A CN105748826A (en) | 2016-04-08 | 2016-04-08 | Traditional Chinese medicine composition for regulating spleen-stomach disharmony as well as oral liquid and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105748826A true CN105748826A (en) | 2016-07-13 |
Family
ID=56334579
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610218820.7A Pending CN105748826A (en) | 2016-04-08 | 2016-04-08 | Traditional Chinese medicine composition for regulating spleen-stomach disharmony as well as oral liquid and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105748826A (en) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101062229A (en) * | 2007-05-19 | 2007-10-31 | 周海萍 | Nutritional medicine for promoting digestion |
| CN104474202A (en) * | 2014-12-04 | 2015-04-01 | 邹士东 | Pharmaceutical composition for treating anorexia |
| CN105056092A (en) * | 2015-08-21 | 2015-11-18 | 北京汉典制药有限公司 | Preparation method of ginseng, poria cocos and white atractylodes rhizome granules and prepared ginseng, poria cocos and white atractylodes rhizome granules |
-
2016
- 2016-04-08 CN CN201610218820.7A patent/CN105748826A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101062229A (en) * | 2007-05-19 | 2007-10-31 | 周海萍 | Nutritional medicine for promoting digestion |
| CN104474202A (en) * | 2014-12-04 | 2015-04-01 | 邹士东 | Pharmaceutical composition for treating anorexia |
| CN105056092A (en) * | 2015-08-21 | 2015-11-18 | 北京汉典制药有限公司 | Preparation method of ginseng, poria cocos and white atractylodes rhizome granules and prepared ginseng, poria cocos and white atractylodes rhizome granules |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100490789C (en) | Enteric coated Chinese medicinal capsule for treating cancer and preparation method thereof | |
| CN101982193B (en) | Traditional Chinese medicine composition for treating pulmonary tuberculosis, preparation method and application thereof | |
| CN102600423A (en) | Preparation method of Chinese medicine for treating hepatic fibrosis | |
| CN103705854A (en) | Semen cassiae, fructus lycii and glossy privet fruit oral solution with functions of tonifying liver and reducing fat | |
| CN102266508A (en) | Chinese medicinal composition for treating drying syndrome and preparation method and application thereof | |
| CN104524416A (en) | Pharmaceutical composition, and use and preparation method of pharmaceutical composition as well as medicine, food and/or health food prepared from pharmaceutical composition | |
| CN103341092B (en) | Preparation method of powder for treating atrophic vaginitis | |
| CN106177477A (en) | A kind of health composition for blood sugar lowering, blood fat reducing and blood pressure lowering | |
| CN106173605A (en) | A kind of Hyperglycemic health care compositions comprising Radix Puerariae and Herba Dendrobii | |
| CN104383183A (en) | Medicinal composition for treating non-alcoholic fatty liver | |
| CN103989820B (en) | Medicament for treating hyperlipidemia | |
| CN103285284B (en) | Medical composition for treating senile vaginitis | |
| CN103301353B (en) | Pharmaceutical composition for treating atrophic vaginitis | |
| CN105832991A (en) | Traditional Chinese medicine composition for treating gastritis | |
| CN105943651A (en) | Traditional Chinese medicine composition for treating premature ovarian failure, and application thereof | |
| WO2021179881A1 (en) | Application of herbal medicine composition in preparation of medicine for preventing and treating coronavirus complicated with lung injury | |
| CN104721256A (en) | Anwei Yang extract as well as preparation method and medical application thereof | |
| CN106177054A (en) | A kind of Hyperglycemic health care compositions comprising Cortex Mori and Pericarpium Citri Reticulatae | |
| CN1287827C (en) | Blood-supplementing traditional Chinese medicine preparation and its production method | |
| CN103920140A (en) | Compound preparation for reducing blood glucose, body weight and fat for human | |
| CN107595954A (en) | A kind of Chinese medicine composition for reducing body fat and treating Central obesity and its application | |
| CN103330867B (en) | Preparation method of powder for treating senile vaginitis | |
| CN105748826A (en) | Traditional Chinese medicine composition for regulating spleen-stomach disharmony as well as oral liquid and preparation method thereof | |
| CN103230552B (en) | Traditional Chinese medicine for treating diabetes mellitus | |
| CN105663876A (en) | Traditional Chinese medicine composition for improving immunity and oral liquid and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20160713 |
|
| RJ01 | Rejection of invention patent application after publication |